AACR: Pembrolizumab Shows Promise in Advanced Lung Cancer
Keytruda (pembrolizumab) is already approved to treat melanoma
Guidance Offered for Managing Conflict With Patients
Good communication is crucial for managing encounters when denying a patient request
AACR: Changes Expected in Breast Cancer Rates
Overall, breast cancer could rise by as much as 50 percent within the next 15 years
AACR: Immune Checkpoint Inhibitors Promising in Melanoma
Pembrolizumab, ipilimumab, and other medications harness immune cells to target cancers
Suboptimal Prescribing Attitudes Could Signal Personal Distress
Med students experiencing depression, alcohol abuse less likely to report impaired colleagues
Clinician-Referred Exercise Program Beneficial in Prostate CA
Clinician referral to a 12-week program ups vigorous exercise levels and improves mental health
Review Compares Shave, Punch Biopsy Methods
No difference in rate of overall positive margins for all lesions; size, morphology impact positivity
Ethical Implications for Looking Up Applicants on Facebook
Misinterpretation of content, implicit bias could undermine fair appraisal for applicants
Medicare Spending Down in Year One of Pioneer ACO
Total adjusted per-beneficiary spending down in ACO group versus control group
Call for Gene Tests in Cancer to Include Normal Tissue
Current practice of only focusing on tumor samples might adversely affect care
